CCO Independent Conference Coverage: Clinical Impact of New Data from EASL 2023 *

Get up to date on the latest practice-changing viral hepatitis data presented at EASL 2023. Review key studies on HBV, HCV, and HDV; view on-demand webcasts; listen to the on-demand podcast; download the slides; and read expert commentaries.

Share

Program Content

Activities

EASL 2023
Clinical Impact of New Data From EASL 2023
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 29, 2023

Activities

EASL 2023 Video Recap
Viral Hepatitis Update: CCO Independent Conference Coverage of EASL 2023
Video
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2023

Activities

EASL 2023 Audio Recap
Viral Hepatitis Update: CCO Independent Conference Coverage of EASL 2023
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: July 11, 2023

Activities

EASL 2023 HCV Elimination Updates
HCV Elimination Efforts: Updates From EASL 2023
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 13, 2023

CT3
Applying New EASL Data and Guidelines to Our Patients With HDV
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 11, 2023

HBV RNA Interference
RNA Interference: An Investigational Strategy for HBV Reported at EASL 2023
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 16, 2023

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.